As of 2025-07-02, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (63.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 65.44 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -197.2%.
The range of the Relative Valuation is (63.66) - (88.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 18.2x | 12.8x |
| Forward P/E multiples | 13.1x - 20.7x | 13.3x |
| Fair Price | (63.66) - (88.71) | (63.61) |
| Upside | -197.3% - -235.6% | -197.2% |
| Date | P/E |
| 2025-06-26 | -12.61 |
| 2025-06-25 | -12.78 |
| 2025-06-24 | -13.06 |
| 2025-06-23 | -12.75 |
| 2025-06-20 | -12.72 |
| 2025-06-18 | -12.61 |
| 2025-06-17 | -12.71 |
| 2025-06-16 | -12.80 |
| 2025-06-13 | -12.90 |
| 2025-06-12 | -12.93 |
| 2025-06-11 | -13.30 |
| 2025-06-10 | -13.82 |
| 2025-06-09 | -13.69 |
| 2025-06-06 | -13.97 |
| 2025-06-05 | -13.58 |
| 2025-06-04 | -13.21 |
| 2025-06-03 | -13.47 |
| 2025-06-02 | -13.06 |
| 2025-05-30 | -12.58 |
| 2025-05-29 | -12.70 |
| 2025-05-28 | -12.23 |
| 2025-05-27 | -12.14 |
| 2025-05-23 | -12.79 |
| 2025-05-22 | -12.72 |
| 2025-05-21 | -12.80 |
| 2025-05-20 | -13.10 |
| 2025-05-19 | -12.57 |
| 2025-05-16 | -12.30 |
| 2025-05-15 | -12.35 |
| 2025-05-14 | -11.75 |
| 2025-05-13 | -11.65 |
| 2025-05-12 | -12.10 |
| 2025-05-09 | -11.77 |
| 2025-05-08 | -12.46 |
| 2025-05-07 | -13.26 |
| 2025-05-06 | -12.87 |
| 2025-05-05 | -13.21 |
| 2025-05-02 | -13.13 |
| 2025-05-01 | -13.09 |
| 2025-04-30 | -13.37 |
| 2025-04-29 | -13.38 |
| 2025-04-28 | -13.21 |
| 2025-04-25 | -13.08 |
| 2025-04-24 | -12.92 |
| 2025-04-23 | -12.28 |
| 2025-04-22 | -12.15 |
| 2025-04-21 | -12.41 |
| 2025-04-17 | -12.67 |
| 2025-04-16 | -12.58 |
| 2025-04-15 | -12.74 |